Congenital Heart Disease (CHD) is one of the most common birth defects, affecting approximately 1% of live births globally and accounting for more than 4.18 million cases in children under five1.

Sahajanand Medical Technologies (SMT) is using its Cocoon Occluder devices to treat congenital heart defects like atrial septal defect and patent foramen ovale. These minimally invasive devices ...

The American Medical Association released its CPT 2026 code set, which includes the new CPT code 63032 fr bone-anchored annular closure, Intrinsic Therapeutics said Oct. 24. The new add-on CPT code ...

An investigational, suture-based large bore closure device intended to deliver fast and reliable vascular closure MENLO PARK, Calif., Oct. 23, 2025 /PRNewswire/ -- Cordis-X today announced that it has ...

Narayana Health City has successfully performed robotic-assisted surgeries for ventricular septal defects in children, enhancing recovery with precision techniques and minimizing scars.

BOSTON, Oct. 24, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., the makers of the Barricaid® Annular Closure Device, announced today that the American Medical Association (AMA) has published a new ...

Benjamin Martin has been promoted by First National Bank to senior vice president and commercial banking team leader. Based out of FNB’s Selinsgrove and State College offices, Martin leads a team of ...

SAN FRANCISCO -- Surprisingly, a course of direct oral anticoagulation (DOAC) may be the safer choice for antithrombotic treatment after left atrial appendage (LAA) occlusion, according to the ANDES ...